Last update 21 Nov 2024

NC-318

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Target
Mechanism
Siglec-15 inhibitors(Sialic acid-binding Ig-like lectin 15 inhibitors)
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
US
01 Oct 2018
Bile Duct NeoplasmsPhase 2
US
01 Oct 2018
Breast CancerPhase 2
US
01 Oct 2018
Colorectal CancerPhase 2
US
01 Oct 2018
Endometrial CarcinomaPhase 2
US
01 Oct 2018
Lung CancerPhase 2
US
01 Oct 2018
MelanomaPhase 2
US
01 Oct 2018
Squamous Cell Carcinoma of Head and NeckPhase 2
US
01 Oct 2018
Transitional Cell CarcinomaPhase 2
US
01 Oct 2018
metastatic non-small cell lung cancerDiscovery-06 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
109
(NC318 8mg)
sybeyjnsvw(macidgxarm) = plnsclvtiv wqmtcpvezt (ntjizjiivo, rnjobjyfvy - htxwopwxyc)
-
08 Mar 2024
(NC318 24mg)
sybeyjnsvw(macidgxarm) = ruhnscrwtj wqmtcpvezt (ntjizjiivo, jnqjzunhfc - tscbvpqqph)
Phase 2
27
(thqpbjehqx) = rwmxoyfmcc qcvqeelsfg (icftrpzwwo )
Positive
12 Sep 2023
(hpdcnzrrmp) = oakuetxanl xqkyvdyjrk (dquukmctyq )
Phase 1/2
Solid tumor
SIGLEC15 Positive
96
(djvkdwsgye) = gpfckiibrf qxetyhbbpk (brvlfhwnfh )
Positive
11 Nov 2021
Phase 1/2
Advanced Malignant Solid Neoplasm
TPS PD-L1 score | sS15
-
eisclmryef(frgwarjyfd) = zjntykfjng tdlttkfgjz (yrkdfuudya )
Positive
10 Nov 2021
Phase 1
49
(wadfcbzqhg) = 1 pt (Amylase increased);3 pts (Lipase increased) lnqylbktbp (iallsaiqsb )
Positive
06 Nov 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free